Boston, MA, United States of America

Mehran Nikan

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Mehran Nikan

Introduction: Mehran Nikan is a distinguished inventor based in Boston, MA, known for his contributions to the field of biotechnology through his innovative patents. With a total of three patents to his name, Nikan is a significant figure in advancing drug delivery systems.

Latest Patents: Among his latest innovations is a patent for "Bioactive conjugates for oligonucleotide delivery." This invention includes self-delivering oligonucleotides designed for efficient RISC entry while minimizing immune responses and off-target effects. It also ensures efficient cellular uptake without the need for additional formulation and facilitates specific tissue distribution. Additionally, he holds a patent titled "Conjugated oligonucleotides," characterized by their efficient and specific tissue distribution, further showcasing his expertise in the area.

Career Highlights: Mehran Nikan is currently affiliated with the University of Massachusetts, where he works at the forefront of scientific research, particularly in the realm of oligonucleotide therapies. His innovative approaches aim to revolutionize how these therapies are delivered, thus improving patient outcomes.

Collaborations: Nikan collaborates with talented colleagues like Matthew Hassler and Maire Osborn, enhancing the impact of his work through shared expertise and diverse perspectives.

Conclusion: As an inventor, Mehran Nikan continues to push the boundaries of biotechnology with his remarkable patents. His achievements not only underscore his dedication to scientific advancement but also position him as a leader in the field of oligonucleotide delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…